CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 69 filers reported holding CIDARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $28,000 | -53.3% | 12,326 | -45.3% | 0.00% | – |
| Q1 2021 | $60,000 | +33.3% | 22,516 | 0.0% | 0.00% | – |
| Q4 2020 | $45,000 | -29.7% | 22,516 | +0.0% | 0.00% | – |
| Q3 2020 | $64,000 | -28.1% | 22,508 | -6.6% | 0.00% | – |
| Q2 2020 | $89,000 | +48.3% | 24,090 | 0.0% | 0.00% | – |
| Q1 2020 | $60,000 | -17.8% | 24,090 | +27.5% | 0.00% | – |
| Q4 2019 | $73,000 | +92.1% | 18,892 | 0.0% | 0.00% | – |
| Q3 2019 | $38,000 | +18.8% | 18,892 | 0.0% | 0.00% | – |
| Q2 2019 | $32,000 | -36.0% | 18,892 | 0.0% | 0.00% | – |
| Q1 2019 | $50,000 | +13.6% | 18,892 | 0.0% | 0.00% | – |
| Q4 2018 | $44,000 | -47.0% | 18,892 | 0.0% | 0.00% | – |
| Q3 2018 | $83,000 | -15.3% | 18,892 | 0.0% | 0.00% | – |
| Q2 2018 | $98,000 | +28.9% | 18,892 | 0.0% | 0.00% | – |
| Q1 2018 | $76,000 | – | 18,892 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,627,670 | $1,533,591 | 1.88% |
| 5AM Venture Management, LLC | 1,134,511 | $1,068,936 | 0.31% |
| Nantahala Capital Management | 2,538,406 | $2,391,686 | 0.20% |
| BVF INC/IL | 6,861,127 | $6,464,554 | 0.17% |
| Monashee Investment Management LLC | 369,099 | $347,765 | 0.14% |
| West Family Investments, Inc. | 368,910 | $347,587 | 0.12% |
| JEPPSON WEALTH MANAGEMENT, LLC | 137,560 | $129,609 | 0.06% |
| XTX Topco Ltd | 202,758 | $191,039 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 136,974 | $129 | 0.01% |
| Callan Capital, LLC | 103,462 | $97,482 | 0.01% |